Vanguard Group Inc Sutro Biopharma, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,115,250 shares of STRO stock, worth $3.79 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,115,250
Previous 4,395,244
6.37%
Holding current value
$3.79 Million
Previous $2.86 Million
2.28%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding STRO
# of Institutions
106Shares Held
59.2MCall Options Held
92.8KPut Options Held
0-
Black Rock Inc. New York, NY6.91MShares$6.36 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.49MShares$5.97 Million0.16% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.09MShares$4.68 Million0.43% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.73MShares$4.35 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA3.06MShares$2.82 Million3.73% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $48M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...